| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $23.75 ▲ +1.50% | Yesterday | $23.25 ▼ -0.63% | Tomorrow's Arcutis Biotherapeutics Inc. Common Stock (ARQT) setup is anchored to $23.40 and targets $23.75 (+1.50%). The near-term read is upside; watch $24.10 / $22.70 because daily realized volatility is about 7.75%. |
Tomorrow's Arcutis Biotherapeutics Inc. Common Stock (ARQT) setup is anchored to $23.40 and targets $23.75 (+1.50%). The near-term read is upside; watch $24.10 / $22.70 because daily realized volatility is about 7.75%. | ||||
| Week | $24.49 ▲ +4.67% | Last Week | $22.94 ▼ -1.96% | The 7-day Arcutis Biotherapeutics Inc. Common Stock model moves from $22.94 to $24.49 (+4.67%). It gives upside momentum context for this stock, so breaks around $24.10 / $22.70 matter more than a single tick. |
The 7-day Arcutis Biotherapeutics Inc. Common Stock model moves from $22.94 to $24.49 (+4.67%). It gives upside momentum context for this stock, so breaks around $24.10 / $22.70 matter more than a single tick. | ||||
| Month | $25.73 ▲ +9.96% | Last Month | $22.42 ▼ -4.18% | The 1-month Arcutis Biotherapeutics Inc. Common Stock target is $25.73 (+9.96%), compared with the live reference near $23.40. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Arcutis Biotherapeutics Inc. Common Stock target is $25.73 (+9.96%), compared with the live reference near $23.40. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $27.58 ▲ +17.87% | Last Year | $21.64 ▼ -7.51% | The 1-year Arcutis Biotherapeutics Inc. Common Stock scenario points to $27.58 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Arcutis Biotherapeutics Inc. Common Stock scenario points to $27.58 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $31.92 ▲ +36.43% | 5 Years Ago | $19.82 ▼ -15.30% | The 5-year Arcutis Biotherapeutics Inc. Common Stock view is $31.92 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Arcutis Biotherapeutics Inc. Common Stock view is $31.92 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $23.40 | Mid |
| Daily Change | -4.37% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 67% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $23.40 | Daily Change | -4.37% |
| Market Cap | $2.90B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.